T-Series

Description

The product is identified by the SPL code 34089-3. No additional specific description details are provided.

Uses and Indications

This drug is indicated for use in specific medical conditions as determined by healthcare professionals. Currently, there are no detailed indications or usage guidelines provided. There are no known teratogenic or nonteratogenic effects associated with this drug. Healthcare providers should evaluate the appropriateness of this drug based on individual patient needs and clinical judgment.

Dosage and Administration

The medication is intended for oral administration only. Healthcare professionals should ensure that patients are informed to take the medication by mouth, adhering strictly to the prescribed dosage regimen. It is essential to follow the specific dosing instructions provided by the prescribing physician to ensure optimal therapeutic outcomes.

Contraindications

There are no contraindications associated with the use of this product. It is not classified as a controlled substance, and there are no known risks of abuse, misuse, or dependence. Additionally, there are no specific instructions indicating that the product should not be taken or used under any circumstances.

Warnings and Precautions

Oral use only is strictly advised for this toothpaste, which contains a fluoride concentration of 1,000 ppm. It is imperative that this product is utilized solely for the purpose of brushing teeth, and care must be taken to avoid swallowing.

This product should be stored out of reach of children to prevent accidental ingestion. In the event of swallowing the toothpaste, immediate medical assistance should be sought, or a poison control center should be contacted without delay.

No specific laboratory tests are recommended for monitoring the use of this toothpaste. However, the emphasis on keeping the product away from children remains a critical precaution to ensure safety.

Side Effects

Patients should be aware that this product is intended for oral use only. It contains a fluoride content of 1,000 ppm, which necessitates caution during use. The toothpaste is specifically designed for brushing teeth and should not be ingested. Care should be taken to avoid swallowing the product.

In the event of accidental ingestion, it is crucial to seek medical assistance or contact a poison control center immediately. Additionally, this product should be kept out of reach of children to prevent any potential misuse or accidental swallowing.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified for this product. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of T-Series (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this toothpaste out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a poison control center is recommended. The toothpaste contains 1,000 ppm fluoride, which is an important consideration for pediatric use.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information available regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. The potential risks and benefits should be carefully evaluated, and alternative treatments may be considered in the absence of established safety profiles. Women of childbearing potential should be counseled on the importance of effective contraception during treatment.

Lactation

Nursing mothers should be aware of the potential for excretion of this product in breast milk. There is an associated risk to breastfed infants when this product is used during lactation. Healthcare professionals should consider these factors when advising lactating mothers on the use of this product.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the event of an overdosage, it is imperative to seek immediate medical assistance. Healthcare professionals should advise patients or caregivers to contact a poison control center without delay if the substance has been ingested.

Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment of the patient's condition is essential. Prompt recognition of symptoms can facilitate timely intervention and management.

Management of overdosage typically involves supportive care and symptomatic treatment. Healthcare providers should monitor the patient closely and implement appropriate measures based on the clinical presentation. It is crucial to follow established protocols for the specific substance involved to ensure optimal patient outcomes.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion or misuse. It is important for patients to understand the potential risks associated with improper access to the medication by young individuals. Providers should emphasize the necessity of storing the medication in a secure location, away from children's sight and reach, to ensure safety.

Storage and Handling

This product is supplied in a configuration that ensures safety and efficacy for oral use only. It is essential to keep the product out of reach of children to prevent accidental ingestion. Once opened, the product must be discarded to maintain safety and integrity.

Storage conditions should be adhered to strictly, although specific temperature ranges and container requirements are not provided. Proper handling is crucial to ensure the product remains effective and safe for use.

Additional Clinical Information

The product is administered orally, with a recommended frequency of up to three times a day. Patients should chew 1 or 2 tablets thoroughly before brushing their teeth. It is important to note that this toothpaste contains 1,000 ppm fluoride and is intended for oral use only. Clinicians should advise patients to avoid swallowing the product and to seek medical assistance or contact a poison control center immediately if ingestion occurs.

No additional information is available regarding laboratory tests, abuse potential, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for T-Series, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)